Abstract
Colorectal cancer (CRC) is a leading cause of cancer-related morbidity and mortality worldwide, with metastatic colorectal cancer (mCRC) accounting for most CRC-associated deaths. Despite advances in systemic therapy, mCRC remains associated with poor prognosis because of its molecular heterogeneity, metastatic potential, and the emergence of therapeutic resistance. Improved understanding of the molecular landscape of mCRC has enabled biomarker-driven treatment strategies that have advanced precision oncology. Among the key signaling pathways involved in mCRC, the epidermal growth factor receptor (EGFR) pathway plays a central role in tumor progression and metastasis. EGFR activation triggers the RAS-RAF-MEK-ERK (rat sarcoma-rapidly accelerated fibrosarcoma-mitogen-activated protein kinase kinase-extracellular signal-regulated kinase) and PI3K-AKT-mTOR (phosphoinositide 3-kinase–protein kinase B–mechanistic target of rapamycin) signaling cascades, promoting cellular proliferation, survival, migration, invasion, angiogenesis, and therapeutic resistance. Genetic alterations involving KRAS (kirsten rat sarcoma viral oncogene homolog), NRAS (neuroblastoma rat sarcoma viral oncogene homolog), BRAF (B-Raf proto-oncogene, serine/threonine kinase), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), HER2 (human epidermal growth factor receptor 2), and PTEN (phosphatase and tensin homolog) frequently dysregulate these pathways and serve as predictive biomarkers for targeted therapy. Anti-EGFR monoclonal antibodies have transformed the treatment landscape of mCRC. However, their clinical benefit is frequently limited by intrinsic and acquired resistance mechanisms driven by molecular alterations, pathway redundancy, compensatory signaling, and tumor heterogeneity. This review examines the role of EGFR signaling in CRC metastasis, the molecular alterations affecting EGFR-associated pathways, and the evolving landscape of EGFR-directed and pathway-focused targeted therapies in mCRC.

This publication has 173 references indexed in Scilit: